Illumina

Illumina

Illumina

Illumina is dedicated to advancing human health by unlocking the power of the genome. Follow @IlluminaLive for live tweets and global event information.
Type
B2c
Founded
1998
Raised
$100M
Follow us
Featured on
Alexa global traffic share
Twitter followers
Latest funding
$100,000,000
Venture capital (Series A) - 2016
Illumina Bill Gates Jeff Bezos
Team Size
1000+
Employees
Pulse 2.0

Illumina (ILMN) Stock: $350 Price Target And Equal-Weight Rating

Pulse 2.0

Illumina (ILMN) Stock: $520 Price Target And Buy Rating

Reuters Tech News

Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case

Pulse 2.0

Illumina (ILMN) Stock: Why The Price Increased Over 0.7%

MedCity News

Illumina sues former employees turned founders of Guardant Health

MedCity News

Illumina Accelerator unveils 7 genomics startups selected for latest funding cycle

Pulse 2.0

Illumina (ILMN) Stock: $460 Price Target And Overweight Rating

Pulse 2.0

Illumina (ILMN) Stock: $562 Price Target From Cowen

Pulse 2.0

Illumina Stock (ILMN): $480 Price Target From Stifel

Pulse 2.0

Illumina Stock (ILMN): $400 Price Target From Barclays

Pulse 2.0

Illumina (ILMN) Stock: $437 Price Target From Baird

MedCity News

Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space?

Pulse 2.0

Illumina Stock Price Increased Over 9% Pre-Market: Why It Happened

neurons.AI

Illumina at JPM: Cloud Analytics Platform, More Diagnostics Focus, Sequencing Updates To Come

MedCity News

Illumina, Helix track spread of more contagious coronavirus variant

MedCity News

Illumina to acquire early cancer detection startup Grail for $8B

TechCrunch

Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal

Xconomy

After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

CNBC Tech

Illumina abandons $1.2 billion deal to buy rival Pacific Biosciences

Xconomy

FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist”